Late Breaking Abstract - Seroprevalence of Bordetella pertussis in chronic obstructive pulmonary disease (COPD) patientsEUROPEAN RESPIRATORY JOURNALIF212020-10-283PRE
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label studyHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52020-08-264OAAI
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label studyHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52020-02-124OAAI
A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing TumorsJOURNAL OF IMMUNOTHERAPYIF2.92015-10-0111OAAI
Nonclinical reproductive and developmental safety evaluation of the MAGE-A3 Cancer Immunotherapeutic, a therapeutic vaccine for cancer treatmentREPRODUCTIVE TOXICOLOGYIF2.82015-01-0111OAAI
The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella tester and Herpes simplex viral thymidine kinases in suicide gene therapyCANCER GENE THERAPYIF52000-11-0123OAAI
Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-β-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinaseCANCER GENE THERAPYIF52000-05-2419PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向